Keizo Kanasaki

机构：Kanazawa Medical University, Shimane University, University of Shimane · ORCID：0000-0002-9563-502X

发表论文 246 篇 · 总被引 11436 次 · h-index 55

代表论文

• Renal Angptl4 is a key fibrogenic molecule in progressive diabetic kidney disease (2024 · Science Advances · 被引 35)
• The aberrant glycolysis in kidney proximal tubule: potential therapeutic target for DKD (2023 · Kidney International · 被引 22)
• Diabetic kidney disease: the kidney disease relevant to individuals with diabetes (2024 · Clinical and Experimental Nephrology · 被引 21)
• Early Clinical Experience of Finerenone in People with Chronic Kidney Disease and Type 2 Diabetes in Japan—A Multi-Cohort Study from the FOUNTAIN (FinerenOne mUltidatabase NeTwork for Evidence generAtIoN) Platform (2024 · Journal of Clinical Medicine · 被引 16)
• Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study (2024 · Frontiers in Pharmacology · 被引 10)
• Liver function effects of SGLT2 inhibitor and GLP ‐1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study) (2025 · Journal of Diabetes Investigation · 被引 9)